These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3857136

  • 1. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.
    Johnson CA, Zimmerman SW, Bayer W, Craig WA.
    Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED, Blair AD.
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC, Demotes-Mainard FM, Bouchet JL, Vincon GA, Martin-Dupont C.
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetics of cefotaxime after i.v. and i.p. administration in patients treated with continual ambulatory peritoneal dialysis (CAPD)].
    Matousovic K, Morávek J, Vítko S, Prát V, Horcicková M, Novák Z, Kuklík R, Krebs V, Janků J.
    Cas Lek Cesk; 1984 Jun 01; 123(22):678-80. PubMed ID: 6331672
    [No Abstract] [Full Text] [Related]

  • 5. [Absorption of ceftizoxime from peritoneal dialysate and its pharmacokinetics in chronic kidney failure patients].
    Gao S, Li P, Liu GL, Wang SX, Chui RL, Yang JP.
    Zhongguo Yao Li Xue Bao; 1992 Jul 01; 13(4):377-80. PubMed ID: 1456067
    [Abstract] [Full Text] [Related]

  • 6. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis.
    Gross ML, Somani P, Ribner BS, Raeader R, Freimer EH, Higgins JT.
    Clin Pharmacol Ther; 1983 Nov 01; 34(5):673-80. PubMed ID: 6313276
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
    Bouchet JL, Albin H, Quentin C, de Barbeyrac B, Vinçon G, Martin-Dupont P, Potaux L, Aparicio M.
    Clin Nephrol; 1988 Jan 01; 29(1):35-40. PubMed ID: 3383462
    [Abstract] [Full Text] [Related]

  • 8. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 2000 Jan 01; 16():280-4. PubMed ID: 11045311
    [Abstract] [Full Text] [Related]

  • 9. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D, Nesić V, Dimitrijević Z.
    Srp Arh Celok Lek; 1999 Jan 01; 127(1-2):28-31. PubMed ID: 10377837
    [Abstract] [Full Text] [Related]

  • 10. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE, Blevins RB, Salem NG, Matzke GR.
    Clin Nephrol; 1984 Nov 01; 22(5):239-43. PubMed ID: 6335067
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetics of ceftizoxime with and without probenecid].
    Adam D, Timmler R.
    Arzneimittelforschung; 1982 Nov 01; 32(4):416-9. PubMed ID: 6285937
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M, Benevent D, Denis F.
    Pathol Biol (Paris); 1985 Jun 01; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [Abstract] [Full Text] [Related]

  • 18. Transperitoneal movement and pharmacokinetics of cefotiam and cefsulodin in patients on continuous ambulatory peritoneal dialysis.
    Brouard R, Tozer TN, Merdjan H, Guillemin A, Baumelou A.
    Clin Nephrol; 1988 Oct 01; 30(4):197-206. PubMed ID: 3214965
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 1999 Oct 01; 15():60-4. PubMed ID: 10682073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.